Cosio S - Search Results

1

Patterns of Failures and Clinical Outcome of Patients with Early-Stage, High-Risk, Node-Negative Endometrial Cancer Treated with Surgery Followed by Adjuvant Platinum-Based Chemotherapy and Vaginal Brachytherapy.

Laliscia C, Cosio S, Morganti R, Mazzotti V, Fabrini MG, Paiar F, Gadducci A. Laliscia C, et al. Among authors: cosio s. Oncology. 2019;96(5):235-241. doi: 10.1159/000492430. Epub 2019 Mar 22. Oncology. 2019. PMID: 30904907

2

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.

Buttitta F, Marchetti A, Gadducci A, Pellegrini S, Morganti M, Carnicelli V, Cosio S, Gagetti O, Genazzani AR, Bevilacqua G. Buttitta F, et al. Among authors: cosio s. Br J Cancer. 1997;75(2):230-5. doi: 10.1038/bjc.1997.38. Br J Cancer. 1997. PMID: 9010031 Free PMC article.

3

Hormone replacement therapy and gynecological cancer.

Gadducci A, Fanucchi A, Cosio S, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1997 Sep-Oct;17(5B):3793-8. Anticancer Res. 1997. PMID: 9427782 Review.

4

Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.

Gadducci A, Ferdeghini M, Fanucchi A, Annicchiarico C, Cosio S, Prontera C, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1997 Nov-Dec;17(6D):4463-6. Anticancer Res. 1997. PMID: 9494551

5

Platinum compounds and paclitaxel in advanced epithelial ovarian cancer.

Gadducci A, Brunetti I, Cosio S, Giannessi PG, Genazzani AR, Conte P. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1997 Nov-Dec;17(6D):4703-8. Anticancer Res. 1997. PMID: 9494592 Review.

6

Analysis of failures after negative second-look in patients with advanced ovarian cancer: an Italian multicenter study.

Gadducci A, Sartori E, Maggino T, Zola P, Landoni F, Fanucchi A, Palai N, Alessi C, Ferrero AM, Cosio S, Cristofani R. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 1998 Feb;68(2):150-5. doi: 10.1006/gyno.1997.4890. Gynecol Oncol. 1998. PMID: 9514797

7

The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.

Gadducci A, Ferdeghini M, Cosio S, Annicchiarico C, Fanucchi A, Prontera C, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1998 Jan-Feb;18(1B):537-9. Anticancer Res. 1998. PMID: 9568174

8

Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma.

Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1998 Sep-Oct;18(5B):3763-5. Anticancer Res. 1998. PMID: 9854491

9

Assessment of the prognostic relevance of serum anti-p53 antibodies in epithelial ovarian cancer.

Gadducci A, Ferdeghini M, Buttitta F, Cosio S, Fanucchi A, Annicchiarico C, Gagetti O, Bevilacqua G, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Gynecol Oncol. 1999 Jan;72(1):76-81. doi: 10.1006/gyno.1998.5101. Gynecol Oncol. 1999. PMID: 9889034

10

Preoperative serum E-cadherin assay in patients with ovarian carcinoma.

Gadducci A, Ferdeghini M, Cosio S, Annicchiarico C, Ciampi B, Bianchi R, Genazzani AR. Gadducci A, et al. Among authors: cosio s. Anticancer Res. 1999 Jan-Feb;19(1B):769-72. Anticancer Res. 1999. PMID: 10216491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters